Back to results
US 8,409,629 B2Granted
Hemostatic agent composition and method of delivery
OwnerJack Mentkow, Lisa Mentkowinventors
Life of this patent
Estimating the term…
Abstract
A hemostatic agent composition that includes a clay hemostatic agent which is inert and non-reactive relative to blood clotting proteins and platelets, yet is capable of accelerating the formation of a stable clot when applied to an actively bleeding wound.
Claims25
A hemostatic agent composition comprising:
- (a) 40-70% by weight of Propylene Glycol;
- (b) 20-40% by weight of beneficiated Hectorite Clay;
- (c) 5-15% by weight of H20;
- (d) 1-10% by weight of Carbomer;
- and
- (e) 1-10% by weight of Triethanolamine;
- wherein the composition comprises a single hemostatic agent, the single hemostatic agent being beneficiated Hectorite Clay, said beneficiated Hectorite Clay having a particle size with 95% of particles being less than 76 microns, and
- wherein the composition facilitates blood clotting, and
- wherein the composition is non-reactive relative to blood clotting proteins and blood platelets.
6 more elements
A method of accelerating blood clotting of a wound comprising the steps of:
- (a) locating a wound;
- (b) providing a hemostatic agent composition;
- and
- (c) applying the composition into the wound:
- wherein the hemostatic agent composition comprises:
- (a) 40-70% by weight of Propylene Glycol;
- (b) 20-40% by weight of beneficiated Hectorite Clay;
- (c) 5-15% by weight of H2O;
- (d) 1-10% by weight of Carbomer;
- and
- (e) 1-10% by weight of Triethanolamine;
- and
- wherein the composition comprises a single hemostatic agent, the single hemostatic agent being beneficiated Hectorite Clay, said beneficiated Hectorite Clay having a particle size with 95% of particles being less than 76 microns, and
- wherein the composition facilitates blood clotting, and wherein the composition is non-reactive relative to blood clotting proteins and blood platelets.
11 more elements
A hemostatic agent delivery system, comprising:
- a hemostatic agent composition;
- and
- a delivery assembly for permitting disposition of an amount of said hemostatic agent composition proximate a hemorrhage site;
- said delivery assembly at least temporarily retaining said amount of said hemostatic agent composition for release upon disposition proximate to the hemorrhage site;
- and
- wherein the hemostatic agent composition comprises:
- (a) 40-70% by weight of Propylene Glycol;
- (b) 20-40% by weight of beneficiated Hectorite Clay;
- (c) 5-15% by weight of H2O.
- (d) 1-10% by weight of Carbomer;
- and
- (e) 1-10% by weight of Triethanolamine;
- and
- wherein the hemostatic agent composition comprises a single hemostatic agent, the single hemostatic agent being beneficiated Hectorite Clay, said beneficiated Hectorite Clay having a particle size with 95% of particles being less than 76 microns, and
- wherein the hemostatic agent composition facilitates blood clotting, and
- wherein the hemostatic agent composition is non-reactive relative to blood clotting proteins and blood platelets.
13 more elements
Dependencies are inferred from the claim text.